Royal Bank Of Canada Issues Positive Forecast for Addus HomeCare (NASDAQ:ADUS) Stock Price

Addus HomeCare (NASDAQ:ADUS) had its price target increased by Royal Bank Of Canada from $134.00 to $139.00 in a research note published on Friday morning,Benzinga reports. The firm currently has an outperform rating on the stock.

ADUS has been the subject of several other reports. UBS Group assumed coverage on Addus HomeCare in a research note on Tuesday, September 2nd. They set a “buy” rating and a $145.00 price objective for the company. Barclays increased their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday. JMP Securities restated a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Wednesday, July 16th. TD Cowen raised their price objective on shares of Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $139.25.

Addus HomeCare Price Performance

NASDAQ ADUS traded down $1.11 on Friday, reaching $113.08. The company’s stock had a trading volume of 184,253 shares, compared to its average volume of 182,638. Addus HomeCare has a 52 week low of $88.96 and a 52 week high of $136.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. The firm has a market cap of $2.08 billion, a PE ratio of 24.96, a price-to-earnings-growth ratio of 1.87 and a beta of 0.88. The business has a 50-day moving average price of $115.31 and a 200 day moving average price of $112.58.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The firm had revenue of $362.30 million during the quarter, compared to analysts’ expectations of $354.48 million. During the same quarter last year, the company earned $1.30 earnings per share. The company’s revenue for the quarter was up 25.0% compared to the same quarter last year. Sell-side analysts expect that Addus HomeCare will post 4.59 EPS for the current year.

Insider Activity

In other news, EVP Brian Poff sold 7,739 shares of the company’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $116.82, for a total transaction of $904,069.98. Following the transaction, the executive vice president owned 56,980 shares of the company’s stock, valued at $6,656,403.60. This represents a 11.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total value of $2,873,750.00. Following the completion of the sale, the chief executive officer owned 166,461 shares of the company’s stock, valued at approximately $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 34,310 shares of company stock valued at $3,958,375 over the last 90 days. 4.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently modified their holdings of the business. AlphaQuest LLC bought a new position in Addus HomeCare in the third quarter valued at approximately $37,000. State of Wyoming acquired a new position in shares of Addus HomeCare in the 2nd quarter valued at $47,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of Addus HomeCare in the 1st quarter valued at $41,000. Raymond James Financial Inc. bought a new position in shares of Addus HomeCare in the 2nd quarter worth $61,000. Finally, Blue Trust Inc. grew its stake in shares of Addus HomeCare by 42.9% during the third quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $63,000 after purchasing an additional 161 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.